Location: New York, NY
CIK: 0001263508 · Show all filings
Period: Q4 2015 (← Previous) (Next →)
Filing Date: Feb 16, 2016
Total Value: $12.07B (85.5% shares, 14.5% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte Corporation | 19,475,316 | $2.112B | 17.5% | $43.21 | +158.1% | COM | 45337C102 |
| — | Seattle Genetics, Inc. | 37,293,728 | $1.674B | 13.9% | $34.64 | — | COM | 812578102 |
| — | Alexion Pharmaceuticals, Inc. | 6,542,599 | $1.248B | 10.3% | $180.77 | — | COM | 015351109 |
| ABBV | AbbVie Inc. | 14,373,538 | $851M | 7.1% | $42.33 | -10.3% | COM | 00287Y109 |
| ACAD | ACADIA Pharmaceuticals Inc. | 20,481,442 | $730M | 6.0% | $14.07 | +150.4% | COM | 004225108 |
| — | Incyte Corporation | 274,500,000 | $597M | 4.9% | $1.21 | — | NOTE 1.25% 11/15/2020 144A | 45337CAL6 |
| — | Incyte Corporation | 259,000,000 | $557M | 4.6% | $1.20 | — | NOTE 0.375% 11/15/2018 144A | 45337CAK8 |
| — | Genomic Health, Inc. | 13,659,264 | $481M | 4.0% | $31.71 | — | COM | 37244C101 |
| — | Anacor Pharmaceuticals, Inc. | 4,198,520 | $474M | 3.9% | $32.42 | — | COM | 032420101 |
| BMRN | BioMarin Pharmaceutical Inc. | 4,115,083 | $431M | 3.6% | $75.89 | +37.5% | COM | 09061G101 |
| — | Dyax Corp. | 8,310,017 | $313M | 2.6% | $15.34 | — | COM | 26746E103 |
| — | DBV Technologies S.A. | 5,462,019 | $198M | 1.6% | $32.87 | — | SPONSORED ADR | 23306J101 |
| — | Acorda Therapeutics, Inc. | 3,580,112 | $153M | 1.3% | $40.15 | — | COM | 00484M106 |
| — | Anacor Pharmaceuticals Inc. | 42,000,000 | $152M | 1.3% | $3.63 | — | NOTE 2.0% 10/15/2021 | 032420AC5 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 14,217,779 | $147M | 1.2% | $7.53 | +32.0% | COM | 09058V103 |
| — | BioMarin Pharmaceutical Inc. | 22,379,000 | $115M | 1.0% | $2.76 | — | NOTE 1.875% 4/23/2017 | 09061GAD3 |
| — | Clovis Oncology Inc. | 129,300,000 | $111M | 0.9% | $1.67 | — | NOTE 2.5% 9/15/2021 | 189464AB6 |
| — | Bellicum Pharmaceuticals, Inc. | 4,865,647 | $98.63M | 0.8% | $22.66 | — | COM | 079481107 |
| — | Gilead Sciences Inc. | 20,944,000 | $93.47M | 0.8% | $2.26 | — | NOTE 1.625% 5/1/2016 | 375558AP8 |
| — | Mirati Therapeutics, Inc. | 2,955,074 | $93.38M | 0.8% | $18.37 | — | COM | 60468T105 |
| CERS | Cerus Corporation | 13,553,275 | $85.66M | 0.7% | $4.68 | +13.6% | COM | 157085101 |
| — | Aquinox Pharmaceuticals, Inc. | 6,747,332 | $84.21M | 0.7% | $13.83 | — | COM | 03842B101 |
| HRTX | Heron Therapeutics, Inc. | 2,907,784 | $77.64M | 0.6% | $13.64 | +96.0% | COM | 427746102 |
| — | ImmunoGen, Inc. | 4,452,445 | $60.42M | 0.5% | $11.68 | — | COM | 45253H101 |
| — | Acorda Therapeutics, Inc. | 51,583,000 | $59.3M | 0.5% | $1.04 | — | NOTE 1.75% 6/15/2021 | 00484MAA4 |
| — | Spark Therapeutics, Inc. | 1,262,382 | $57.2M | 0.5% | $77.50 | — | COM | 84652J103 |
| — | Invitae Corporation | 6,554,967 | $53.82M | 0.4% | $16.76 | — | COM | 46185L103 |
| NBIX | Neurocrine Biosciences, Inc. | 850,739 | $48.13M | 0.4% | $28.36 | +79.2% | COM | 64125C109 |
| — | Versartis, Inc. | 3,241,783 | $40.17M | 0.3% | $22.68 | — | COM | 92529L102 |
| SGMO | Sangamo BioSciences, Inc. | 4,055,876 | $37.03M | 0.3% | $12.13 | -36.5% | COM | 800677106 |
| HALO | Halozyme Therapeutics, Inc. | 1,931,057 | $33.47M | 0.3% | $6.50 | +145.3% | COM | 40637H109 |
| — | Intra-Cellular Therapies, Inc. | 609,166 | $32.77M | 0.3% | $37.28 | — | COM | 46116X101 |
| — | Medivation, Inc. | 659,752 | $31.89M | 0.3% | $42.50 | — | COM | 58501N101 |
| — | Progenics Pharmaceuticals, Inc. | 4,350,808 | $26.67M | 0.2% | $4.44 | — | COM | 743187106 |
| GILD | Gilead Sciences, Inc. | 249,995 | $25.3M | 0.2% | $36.21 | +101.3% | COM | 375558103 |
| TGTX | TG Therapeutics, Inc. | 2,003,991 | $23.91M | 0.2% | $4.61 | +174.2% | COM | 88322Q108 |
| — | Exelixis, Inc. | 20,000,000 | $23.26M | 0.2% | $1.20 | — | NOTE 4.25% 8/15/2019 | 30161QAC8 |
| GLPG | Galapagos NV | 369,276 | $23.22M | 0.2% | $51.50 | — | SPON ADR | 36315X101 |
| — | aTyr Pharma Inc. | 2,335,125 | $22.95M | 0.2% | $18.52 | — | COM | 002120103 |
| — | Achillion Pharmaceuticals, Inc. | 2,000,000 | $21.58M | 0.2% | $8.32 | — | COM | 00448Q201 |
| — | Idera Pharmaceuticals, Inc. | 6,983,107 | $21.58M | 0.2% | $3.05 | — | COM NEW | 45168K306 |
| CPRX | Catalyst Pharmaceuticals, Inc. | 8,275,630 | $20.27M | 0.2% | $2.61 | +9.6% | COM | 14888U101 |
| ALKS | Alkermes PLC | 250,251 | $19.86M | 0.2% | $70.02 | 0.0% | SHS | G01767105 |
| — | XenoPort, Inc. | 3,475,672 | $19.08M | 0.2% | $5.27 | — | COM | 98411C100 |
| — | Novavax, Inc. | 2,195,687 | $18.42M | 0.2% | $5.28 | — | COM | 670002104 |
| — | Array BioPharma Inc. | 4,310,666 | $18.19M | 0.2% | $6.65 | — | COM | 04269X105 |
| INSM | Insmed, Inc. | 1,000,000 | $18.15M | 0.2% | $14.99 | +17.6% | COM PAR $.01 | 457669307 |
| — | Advanced Accelerator Applications SA | 567,454 | $17.74M | 0.1% | $31.27 | — | SPONSORED ADS | 00790T100 |
| — | Aegerion Pharmaceuticals, Inc. | 26,517,000 | $17.55M | 0.1% | $0.75 | — | NOTE 2.0% 8/15/2019 | 00767EAB8 |
| — | Derma Sciences, Inc. | 3,752,390 | $17.15M | 0.1% | $12.19 | — | COM PAR $.01 | 249827502 |
| — | Foamix Pharmaceuticals Ltd. | 2,046,967 | $16.6M | 0.1% | $7.46 | — | SHS | M46135105 |
| — | BioMarin Pharmaceutical Inc. | 12,228,000 | $15.7M | 0.1% | $1.06 | — | NOTE 0.75% 10/15/2018 | 09061GAE1 |
| — | Zogenix, Inc. | 1,000,000 | $14.74M | 0.1% | $13.50 | — | COM NEW | 98978L204 |
| — | Alcobra Ltd. | 2,336,359 | $14.67M | 0.1% | $5.61 | — | SHS | M2239P109 |
| — | Lion Biotechnologies, Inc. | 1,817,429 | $14.03M | 0.1% | $11.31 | — | COM | 53619R102 |
| — | Dimension Therapeutics, Inc. | 1,234,481 | $13.93M | 0.1% | $11.28 | — | COM | 25433V105 |
| RARE | Ultragenyx Pharmaceutical Inc. | 123,894 | $13.9M | 0.1% | $51.09 | +95.7% | COM | 90400D108 |
| — | Global Blood Therapeutics, Inc. | 400,000 | $12.93M | 0.1% | $37.24 | — | COM | 37890U108 |
| XNCR | Xencor, Inc. | 872,072 | $12.75M | 0.1% | $11.07 | +21.5% | COM | 98401F105 |
| MGNX | MacroGenics, Inc. | 363,676 | $11.26M | 0.1% | $23.98 | +26.7% | COM | 556099109 |
| — | Dermira, Inc. | 275,000 | $9.518M | 0.1% | $21.44 | — | COM | 24983L104 |
| — | Concert Pharmaceuticals, Inc. | 495,908 | $9.407M | 0.1% | $10.71 | — | COM | 206022105 |
| ASND | Ascendis Pharma A/S | 505,521 | $9.261M | 0.1% | $17.72 | — | SPONSORED ADR | 04351P101 |
| — | bluebird bio, Inc. | 141,105 | $9.062M | 0.1% | $29.38 | — | COM | 09609G100 |
| PRQR | ProQR Therapeutics N.V. | 988,299 | $8.578M | 0.1% | $17.70 | -35.0% | SHS EURO | N71542109 |
| LGND | Ligand Pharmaceuticals Incorporated | 73,386 | $7.957M | 0.1% | $41.68 | +48.1% | COM NEW | 53220K504 |
| — | Ignyta, Inc. | 571,000 | $7.651M | 0.1% | $8.30 | — | COM | 451731103 |
| — | Aerie Pharmaceuticals, Inc. | 299,356 | $7.289M | 0.1% | $17.96 | — | COM | 00771V108 |
| — | Endocyte, Inc. | 1,695,865 | $6.8M | 0.1% | $4.47 | — | COM | 29269A102 |
| AGIO | Agios Pharmaceuticals, Inc. | 100,000 | $6.492M | 0.1% | $27.47 | +138.7% | COM | 00847X104 |
| — | Arrowhead Research Corp. | 1,009,509 | $6.208M | 0.1% | $9.76 | — | COM NEW | 042797209 |
| — | Sage Therapeutics, Inc. | 105,000 | $6.122M | 0.1% | $43.36 | — | COM | 78667J108 |
| — | Curis, Inc. | 1,999,303 | $5.818M | 0.0% | $2.72 | — | COM | 231269101 |
| — | Akari Therapeutics PLC | 395,882 | $5.74M | 0.0% | $23.99 | — | SPONSORED ADR | 00972G108 |
| OMER | Omeros Corporation | 336,226 | $5.289M | 0.0% | $12.37 | +11.7% | COM | 682143102 |
| — | NeuroDerm Ltd. | 305,000 | $5.2M | 0.0% | $15.24 | — | ORD SHS | M74231107 |
| — | Osiris Therapeutics, Inc. | 499,193 | $5.182M | 0.0% | $16.34 | — | COM | 68827R108 |
| — | Trevena, Inc. | 450,000 | $4.725M | 0.0% | $10.35 | — | COM | 89532E109 |
| — | Proteon Therapeutics, Inc. | 298,591 | $4.631M | 0.0% | $12.06 | — | COM | 74371L109 |
| — | Aimmune Therapeutics, Inc. | 250,000 | $4.613M | 0.0% | $25.32 | — | COM | 00900T107 |
| — | Medgenics Inc. | 765,000 | $4.605M | 0.0% | $6.02 | — | COM NEW | 58436Q203 |
| — | Corsicanto Ltd. | 5,000,000 | $4.48M | 0.0% | $0.90 | — | NOTE 3.5% 1/15/2032 | 220480AB3 |
| — | Seres Therapeutics, Inc. | 125,000 | $4.386M | 0.0% | $41.50 | — | COM | 81750R102 |
| — | Amarin Corporation plc | 2,205,710 | $4.169M | 0.0% | $2.34 | — | SPONS ADR NEW | 023111206 |
| — | Sunesis Pharmaceuticals, Inc. | 4,450,000 | $3.994M | 0.0% | $2.09 | — | COM NEW | 867328601 |
| — | Loxo Oncology, Inc. | 137,735 | $3.919M | 0.0% | $17.33 | — | COM | 548862101 |
| — | Epizyme, Inc. | 232,481 | $3.724M | 0.0% | $21.12 | — | COM | 29428V104 |
| IONS | Ionis Pharmaceuticals, Inc. | 57,140 | $3.539M | 0.0% | $53.96 | 0.0% | COM | 462222100 |
| — | Juno Therapeutics, Inc. | 80,000 | $3.518M | 0.0% | $52.22 | — | COM | 48205A109 |
| — | Vitae Pharmaceuticals, Inc. | 187,597 | $3.396M | 0.0% | $11.71 | — | COM | 92847N103 |
| — | Nabriva Therapeutics AG | 350,000 | $3.367M | 0.0% | $9.50 | — | SPONSORED ADR | 62957M104 |
| — | Pronai Therapeutics, Inc. | 200,000 | $3.008M | 0.0% | $20.52 | — | COM | 74346L101 |
| — | Immune Design Corp. | 148,937 | $2.991M | 0.0% | $20.65 | — | COM | 45252L103 |
| — | Karyopharm Therapeutics Inc. | 216,990 | $2.875M | 0.0% | $31.09 | — | COM | 48576U106 |
| — | Affimed N.V. | 400,000 | $2.848M | 0.0% | $6.30 | — | COM | N01045108 |
| — | Flexion Therapeutics, Inc. | 146,642 | $2.826M | 0.0% | $19.27 | — | COM | 33938J106 |
| — | Array BioPharma Inc. | 3,000,000 | $2.816M | 0.0% | $1.25 | — | NOTE 3.0% 6/1/2020 | 04269XAA3 |
| — | Ophthotech Corporation | 35,649 | $2.8M | 0.0% | $32.35 | — | COM | 683745103 |
| NTRA | Natera, Inc. | 250,000 | $2.7M | 0.0% | $16.90 | -43.7% | COM | 632307104 |
| — | Trillium Therapeutics, Inc. | 211,792 | $2.671M | 0.0% | $12.74 | — | COM NEW | 89620X506 |
| ENTA | Enanta Pharmaceuticals, Inc. | 75,357 | $2.488M | 0.0% | $19.50 | +67.1% | COM | 29251M106 |
| — | Protalix BioTherapeutics, Inc. | 3,423,000 | $2.375M | 0.0% | $0.76 | — | NOTE 4.50% 9/15/2018 | 74365AAB7 |
| — | Ohr Pharmaceuticals, Inc. | 370,370 | $2.274M | 0.0% | $2.54 | — | COM NEW | 67778H200 |
| — | Stemline Therapeutics, Inc. | 333,497 | $2.104M | 0.0% | $23.84 | — | COM | 85858C107 |
| — | Mast Therapeutics, Inc. | 4,797,442 | $2.016M | 0.0% | $0.56 | — | COM | 576314108 |
| IRWD | Ironwood Pharmaceuticals, Inc. | 169,163 | $1.961M | 0.0% | $11.63 | -16.9% | COM CL A | 46333X108 |
| — | MediWound Ltd. | 225,000 | $1.922M | 0.0% | $11.38 | — | ORD SHS | M68830104 |
| — | Assembly Biosciences, Inc. | 250,000 | $1.878M | 0.0% | $13.24 | — | COM | 045396108 |
| — | Dynavax Technologies Corporation | 75,000 | $1.812M | 0.0% | $24.55 | — | COM NEW | 268158201 |
| AUPH | Aurinia Pharmaceuticals Inc. | 711,499 | $1.789M | 0.0% | $3.55 | -23.5% | COM | 05156V102 |
| — | CytRx Corporation | 659,995 | $1.749M | 0.0% | $3.49 | — | COM PAR $.001 | 232828509 |
| CLLS | Cellectis S.A. | 50,000 | $1.552M | 0.0% | $34.58 | — | SPONSORED ADS | 15117K103 |
| — | Marinus Pharmaceuticals, Inc. | 200,000 | $1.528M | 0.0% | $6.47 | — | COM | 56854Q101 |
| — | Acceleron Pharma, Inc. | 28,765 | $1.403M | 0.0% | $39.60 | — | COM | 00434H108 |
| — | Tenax Therapeutics Inc. | 420,000 | $1.378M | 0.0% | $3.58 | — | COM | 88032L100 |
| — | Palatin Technologies, Inc. | 2,050,000 | $1.361M | 0.0% | $0.73 | — | COM PAR $ .01 | 696077403 |
| ADAPY | Adaptimmune Therapeutics plc | 100,000 | $1.206M | 0.0% | $18.33 | — | SPONDS ADR | 00653A107 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 11,340 | $1.068M | 0.0% | $77.42 | +19.8% | COM | 02043Q107 |
| — | Chimerix, Inc. | 115,216 | $1.031M | 0.0% | $40.26 | — | COM | 16934W106 |
| — | BioDelivery Sciences International, Inc. | 210,021 | $1.006M | 0.0% | $5.21 | — | COM | 09060J106 |
| ALDX | Aldeyra Therapeutics, Inc. | 142,000 | $963K | 0.0% | $10.20 | -34.2% | COM | 01438T106 |
| ABUS | Arbutus Biopharma Corporation | 180,582 | $804K | 0.0% | $8.87 | -38.2% | COM | 03879J100 |
| — | Five Prime Therapeutics, Inc. | 19,247 | $799K | 0.0% | $16.80 | — | COM | 33830X104 |
| — | Discovery Laboratories, Inc. | 3,569,643 | $764K | 0.0% | $1.95 | — | COM NEW | 254668403 |
| — | Ritter Pharmaceuticals, Inc. | 400,000 | $680K | 0.0% | $4.45 | — | COM | 767836109 |
| — | Achaogen, Inc. | 100,000 | $574K | 0.0% | $15.46 | — | COM | 004449104 |
| QURE | UniQure N.V. | 30,000 | $496K | 0.0% | $15.95 | +16.2% | SHS | N90064101 |
| — | Foundation Medicine, Inc. | 20,892 | $440K | 0.0% | $25.16 | — | COM | 350465100 |
| — | ChemoCentryx, Inc. | 49,064 | $397K | 0.0% | $14.14 | — | COM | 16383L106 |
| — | La Jolla Pharmaceutical Company | 13,746 | $371K | 0.0% | $10.24 | — | COM PAR $.0001 2 | 503459604 |
| — | Aptose Biosciences, Inc. | 33,397 | $84,000 | 0.0% | $5.91 | — | COM NEW | 03835T200 |
| — | Cyclacel Pharmaceuticals, Inc. | 13,253 | $52,000 | 0.0% | $7.20 | — | PFD CONV EX 6% | 23254L207 |
| — | BioTime, Inc. | 20,084 | $24,000 | 0.0% | $1.07 | — | *W EXP 10/01/201 | 09066L162 |